ClearPoint Neuro
(NASDAQ) CLPT
ClearPoint Neuro Financials at a Glance
Market Cap
$307.91M
Revenue (TTM)
$36.97M
Net Income (TTM)
$25.54M
EPS (TTM)
$-0.90
P/E Ratio
-11.51
Dividend
$0.00
Beta (Volatility)
1.84 (High)
Dividend
$0.00
Beta (Volatility)
1.84 (High)
Price
$10.47
Volume
1,629
Open
$10.41
Price
$10.47
Volume
1,629
Open
$10.41
Previous Close
$10.38
Daily Range
$10.41 - $10.74
52-Week Range
$8.27 - $30.10
Dividend
$0.00
Beta (Volatility)
1.84 (High)
Price
$10.47
Volume
1,629
Open
$10.41
Previous Close
$10.38
Daily Range
$10.41 - $10.74
52-Week Range
$8.27 - $30.10
CLPT News
CLPT: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout ClearPoint Neuro
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
172
CEO
Joseph Michael Burnett, MBA
Website
www.clearpointneuro.comHeadquarters
Solana Beach, CA 92075, US
CLPT Financials
Key Financial Metrics (TTM)
Gross Margin
61%
Operating Margin
-65%
Net Income Margin
-69%
Return on Equity
-96%
Return on Capital
-28%
Return on Assets
-26%
Earnings Yield
-8.69%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$307.91M
Shares Outstanding
29.66M
Volume
1.63K
Short Interest
0.00%
Avg. Volume
800.72K
Financials (TTM)
Gross Profit
$22.69M
Operating Income
$24.16M
EBITDA
$21.93M
Operating Cash Flow
$23.93M
Capital Expenditure
$522.00K
Free Cash Flow
$24.45M
Cash & ST Invst.
$45.92M
Total Debt
$58.23M
ClearPoint Neuro Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$10.41M
+34.0%
Gross Profit
$6.40M
+34.5%
Gross Margin
61.52%
N/A
Market Cap
$307.91M
N/A
Market Cap/Employee
$2.68M
N/A
Employees
115
N/A
Net Income
$7.79M
-44.6%
EBITDA
$6.19M
-20.7%
Quarterly Fundamentals
Net Cash
$12.31M
-174.4%
Accounts Receivable
$7.26M
+54.1%
Inventory
$8.36M
+21.8%
Long Term Debt
$57.54M
+1810.9%
Short Term Debt
$694.00K
+24.6%
Return on Assets
-26.13%
N/A
Return on Invested Capital
-27.78%
N/A
Free Cash Flow
$12.13M
-705.4%
Operating Cash Flow
$12.08M
-871.8%